Getting more women into drug R&D remains critical for boosting health outcomes. But in some disease areas, pharma is still falling behind.
Where female participation in clinical trials has caught up — and where gaps remain
Getting more women into drug R&D remains critical for boosting health outcomes. But in some disease areas, pharma is still falling behind.
Source: PharmaVoice